No benefit of colchicine to prevent AF or myocardial injury after non-cardiac surgery
Nature Reviews Cardiology, Published online: 04 September 2023; doi:10.1038/s41569-023-00928-5According to data from the COP-AF trial, anti-inflammatory therapy with colchicine does not reduce the risk of perioperative atrial fibrillation or myocardial injury in patients undergoing major non-cardiac thoracic surgery.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Gregory B. Lim Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular & Thoracic Surgery | Colchicine | Colcrys | Heart